Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ABSSSI”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Testing effectiveness (Phase 2)Study completedNCT02269319
What this trial is testing

MRX-I Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection

Who this might be right for
Bacterial Infections
MicuRx 120
Large-scale testing (Phase 3)Study completedNCT03405064
What this trial is testing

Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Who this might be right for
Acute Bacterial Skin and Skin Structure Infections
Wockhardt 501
Testing effectiveness (Phase 2)Study completedNCT03747497
What this trial is testing

Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection

Who this might be right for
Skin Diseases, BacterialGram-Positive Bacterial Infections
MicuRx 196
Large-scale testing (Phase 3)Study completedNCT03176134
What this trial is testing

Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Participants From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (MK-1986-018)

Who this might be right for
Acute Bacterial Skin and Skin Structure Infections
Merck Sharp & Dohme LLC 100
Early research (Phase 1)Study completedNCT06394518
What this trial is testing

Phase 1, Single-Dose and Multiple-Dose Continuous Intravenous Infusions of TNP-2092 for Injection in Healthy Chinese Participants

Who this might be right for
Acute Bacterial Skin and Skin Structure Infection (ABSSSI)Prosthetic Joints Infection (PJI)
TenNor Therapeutics Inc. 32
Large-scale testing (Phase 3)Study completedNCT01421511
What this trial is testing

TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Who this might be right for
Skin and Subcutaneous Tissue Bacterial Infections
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 666
Testing effectiveness (Phase 2)UnknownNCT03732365
What this trial is testing

Phase 2 Randomized Study to Compare Ultrasonic Drug Delivery to Standard of Care for the Treatment of Infections in Non-Healing Wounds

Who this might be right for
Acute Bacterial Skin and Skin Structure Infection (ABSSSI)Non-healing Wound
Sonescence, Inc. 30
Large-scale testing (Phase 3)Study completedNCT01252732
What this trial is testing

Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection

Who this might be right for
Wound InfectionAbscessSystemic Inflammation+1 more
Melinta Therapeutics, Inc. 1,019
Not applicableStudy completedNCT04959799
What this trial is testing

Dalbavancin Real-life Utilization in Diabetic Patients Suffering From Infections (DALBADIA)

Who this might be right for
DiabetesInfection
Aziende Chimiche Riunite Angelini Francesco S.p.A 98
Not applicableStudy completedNCT04298463
What this trial is testing

Retrospective Effectiveness Study of Dalbavancin and Other Standard of Care of the Same Class in Patients With ABSSSI

Who this might be right for
Acute Bacterial Skin and Skin Structure Infection
Aziende Chimiche Riunite Angelini Francesco S.p.A 184
Post-approval studies (Phase 4)Study completedNCT03233438
What this trial is testing

Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Who this might be right for
Bacterial InfectionsAcute Bacterial Skin and Skin Structure Infection
Allergan 91
Post-approval studies (Phase 4)Study completedNCT02452918
What this trial is testing

Evaluate the Safety of a Single Intravenous (IV) Dose of Orbactiv (Oritavancin) in Participants on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Who this might be right for
Acute Bacterial Skin and Skin Structure Infection
The Medicines Company 17
Post-approval studies (Phase 4)Study completedNCT02925416
What this trial is testing

Safety of Either a Single or Two Intravenous Doses of Orbactiv in Participants With Acute Bacterial Skin and Skin Structure Infection

Who this might be right for
Skin Diseases, Bacterial
The Medicines Company 22
Early research (Phase 1)Study completedNCT04919954
What this trial is testing

Tebipenem (SPR994) Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis

Who this might be right for
DiabetesWound InfectionABSSSI+1 more
Hartford Hospital 12
Not applicableUnknownNCT01724671
What this trial is testing

Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline

Who this might be right for
MRSA InfectionBacteremiaABSSSI+1 more
CPL Associates 30
Early research (Phase 1)Study completedNCT03873987
What this trial is testing

Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients

Who this might be right for
Acute Bacterial Skin and Skin Structure Infection
Melinta Therapeutics, Inc. 102
Large-scale testing (Phase 3)Study completedNCT01170221
What this trial is testing

TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.

Who this might be right for
Skin and Subcutaneous Tissue Bacterial Infections
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 667
Testing effectiveness (Phase 2)Study completedNCT00949130
What this trial is testing

Comparative Study of NXL103 Versus Linezolid in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Who this might be right for
Acute Bacterial Skin and Skin Structure Infections
Novexel Inc 180
Large-scale testing (Phase 3)Study completedNCT02877927
What this trial is testing

Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI

Who this might be right for
Bacterial InfectionsSkin Structures and Soft Tissue Infections
Paratek Pharmaceuticals Inc 735
Large-scale testing (Phase 3)Study completedNCT02600611
What this trial is testing

Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1

Who this might be right for
Skin Structures and Soft Tissue Infections
Motif Bio 600
Load More Results